ZBTB9: Potential Drug Target Or Biomarker for Various Diseases

Target Name: ZBTB9

NCBI ID: G221504

ZBTB9

Other Name(s): ZBTB9_HUMAN | Zinc finger and BTB domain-containing protein 9 | zinc finger and BTB domain containing 9 | ZNF919 | Zinc finger and BTB domain containing 9

ZBTB9: Potential Drug Target Or Biomarker for Various Diseases

ZBTB9 (ZBTB9_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, and kidneys. It is a key regulator of cell growth and differentiation, and is involved in the development and maintenance of tissues. ZBTB9 has also been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders. As a result, ZBTB9 has potential as a drug target or biomarker for a variety of diseases.

The ZBTB9 gene is located on chromosome 6p and encodes a protein that is composed of 1,942 amino acids. ZBTB9 is expressed in a variety of tissues in the human body, including the brain, heart, and kidneys. It is primarily expressed in the brain, where it is involved in the development and maintenance of neural stem cells and the formation of neuronal networks. ZBTB9 is also expressed in other tissues, including the heart and kidneys, where it is involved in the regulation of blood pressure and the maintenance of kidney function.

One of the key functions of ZBTB9 is its role as a regulator of cell growth and differentiation. This is accomplished through the regulation of the Wnt signaling pathway, a critical pathway that regulates cell growth and development. ZBTB9 is a key regulator of the Wnt signaling pathway, and has been shown to play a role in the development and maintenance of tissues.

In addition to its role in cell growth and differentiation, ZBTB9 is also involved in the regulation of several other processes that are important for human health. For example, ZBTB9 has been shown to play a role in the development and progression of cancer, particularly breast cancer. It has also been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Additionally, ZBTB9 has been linked to a variety of developmental disorders, including Down syndrome and Fragile X syndrome.

As a result of its involvement in so many important processes in human health, ZBTB9 has significant potential as a drug target or biomarker. For example, it may be a good candidate for treatment of a variety of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Fragile X syndrome. It may also be a useful biomarker for monitoring the effectiveness of potential therapeutic interventions. Additionally, ZBTB9 may have potential as a target for other diseases, such as cancer, where it has been shown to play a role in the development and progression of certain types of cancer.

In conclusion, ZBTB9 is a protein that is expressed in various tissues of the human body, including the brain, heart, and kidneys. It is involved in the regulation of cell growth and differentiation, and has been shown to play a role in the development and maintenance of tissues. ZBTB9 has potential as a drug target or biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders. Further research is needed to fully understand the role of ZBTB9 in human health and to develop effective treatments.

Protein Name: Zinc Finger And BTB Domain Containing 9

Functions: May be involved in transcriptional regulation

The "ZBTB9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZBTB9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets